Patent Yard Sign in
Expired Canadian patentCanada

Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications

CA 2321881 C · Owner: Arrang, Jean-Michel · Inventors: Schwartz, Jean-Charles; Arrang, Jean-Michel; Garbarg, Monique

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Use of a compound of formula (A), wherein: W is a residue which imparts antagonistic and/or agonistic activity at histamine H3-receptors when attached to an imidazole ring in 4(5) position; R1 and R2 may be identical or different and represent each independently a lower alkyl or cycloalkyl or taken , together with the nitrogen atom to which they are attached a saturated , nitrogen-containing ring (i) as defined a non-aromatic unsaturated nitrogen-, containing ring (ii) as defined a morpholino group, or a N-substituted piperazino group as defined for preparing medicaments acting as antagonists and/or agonists at the H3-receptors of histamine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 29, 1999 and granted January 18, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 29, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 29, 1999
GrantedJanuary 18, 2011
Term endedJuly 29, 2019
Patent numberCA 2321881 C
Classification (IPC)A61K31/44 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedJuly 29, 1999Patent grantedJan 18, 2011Term endedJuly 29, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.